Softwr

Healthcare · head to head

Koa Health vs Paige

Koa Health logo

Koa Health

Healthcare

Employer and health plan digital mental health, acquired by PsychPlus in June 2026

From
On request
Rated
-
Full reviewWebsite
Paige logo

Paige

Healthcare

Digital pathology AI holding the first FDA De Novo authorisation for a pathology algorithm, now part of Tempus

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Koa Health psychPlus acquired Koa Health in June 2026, so buyers are now contracting with the technology arm of an American psychiatry provider group rather than a European digital health company, and roadmap, data residency and European product investment should all be re-examined before renewal.; Paige the FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.
  • They diverge on capability: Koa Health covers Stepped care triage, Paige covers Paige Prostate Detect.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Koa Health and Paige actually diverge.

Attributes where Koa Health and Paige differ
AttributeKoa HealthPaige
PlatformsWeb, iOS, AndroidWeb, Cloud, On-premise

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Koa Health

  • Stepped care triage
  • Self guided digital modules
  • Coaching tier
  • Licensed clinical care
  • Employer and plan reporting
  • Multi country delivery
  • Clinical governance

Only in Paige

  • Paige Prostate Detect
  • Paige Prostate Grade and Quantify
  • Perineural invasion detection
  • Breast and lymph node applications
  • FullFocus viewer
  • Foundation models
  • OmniScreen
  • Paige Alba

What people use each for

The jobs each tool is most often brought in to do.

Koa Health

  • An employer that wants something between a meditation app and a full clinical benefit, with triage deciding which members need a cliniciannot Paige
  • A European health plan needing a digital mental health offering with clinical governance and local language deliverynot Paige
  • A health system wanting to absorb low acuity behavioural health demand before it reaches scarce psychiatry appointmentsnot Paige
  • A multinational standardising a stepped care pathway across several European markets under one contractnot Paige

Paige

  • A reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffablenot Koa Health
  • A pathology department already digitised that wants a documented safety net against missed small foci of cancernot Koa Health
  • A hospital laboratory struggling to recruit uropathology subspecialists and needing consistency across generalist reportingnot Koa Health
  • A pharmaceutical company needing consistent biomarker scoring across trial sites rather than site-by-site pathologist variabilitynot Koa Health

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Koa Health

  • PsychPlus acquired Koa Health in June 2026, so buyers are now contracting with the technology arm of an American psychiatry provider group rather than a European digital health company, and roadmap, data residency and European product investment should all be re-examined before renewal.
  • Stepped care only produces savings when triage is accurate, and members routed to a self guided module when they believe they need a therapist commonly disengage entirely, which a utilisation report records as low engagement rather than as a triage failure.
  • Pricing is per employee or per member per month across the eligible population, so an employer with modest engagement pays for everyone in order to serve a minority.
  • Clinician availability and language coverage differ substantially by country, so a multinational contract that reads as one global standard delivers a materially different experience in secondary markets.
  • Koa competes against much larger and better funded benefits vendors in the United States, and the acquisition does not change the fact that its brand recognition with American benefits consultants is low, which affects broker driven shortlists.

Paige

  • The FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.
  • The algorithm is worthless without a digital pathology programme already running, and slide scanning, storage and workflow typically cost far more than the software licence.
  • Tempus acquired Paige in 2025, so the roadmap now competes for attention inside a genomics-led business, and the pathology-only buyer is no longer the primary customer.
  • Scanner compatibility is a hard constraint rather than a preference, and a laboratory with an unsupported scanner fleet cannot use the authorised indication at all.
  • Pricing is per case or per slide and unpublished, so a laboratory cannot model cost per reported case without entering a sales process.

Pricing, plan by plan

Koa Health

On request
  • Koa Health$undefined/year
    • Per employee per month or per member per month, quoted not published
    • Rate depends on which steps of the care ladder are included
    • Clinical tier access priced separately from digital content access

Paige

On request
  • Paige clinical applications$undefined/year
    • Priced per case or per slide analysed under annual agreement
    • Prostate, breast and other applications licensed separately
    • Requires compatible whole slide scanner and the FullFocus viewer for the authorised indication

Which should you pick?

Choose Koa Health if

  • You need stepped care triage.
  • You work on Web, iOS, Android.
  • You also want self guided digital modules.
Koa Health review

Choose Paige if

  • You need paige prostate detect.
  • You work on Web, Cloud, On-premise.
  • You also want paige prostate grade and quantify.
Paige review

Questions people ask

Is Koa Health or Paige better?
Neither clearly leads. Koa Health starts at On request and Paige at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Koa Health or Paige?
Koa Health starts at On request and Paige at On request.
Does Koa Health or Paige run on more platforms?
Koa Health runs on Web, iOS, Android. Paige runs on Web, Cloud, On-premise.
What is Koa Health best used for?
Koa Health is most often used for an employer that wants something between a meditation app and a full clinical benefit, with triage deciding which members need a clinician, a european health plan needing a digital mental health offering with clinical governance and local language delivery, a health system wanting to absorb low acuity behavioural health demand before it reaches scarce psychiatry appointments, a multinational standardising a stepped care pathway across several european markets under one contract. Of those, an employer that wants something between a meditation app and a full clinical benefit, with triage deciding which members need a clinician and a european health plan needing a digital mental health offering with clinical governance and local language delivery are not what Paige is typically brought in for.
What can Koa Health do that Paige cannot?
Koa Health covers Stepped care triage, Self guided digital modules, Coaching tier, Licensed clinical care. Paige covers Paige Prostate Detect, Paige Prostate Grade and Quantify, Perineural invasion detection, Breast and lymph node applications.

Answered from the vendors’ own pages

Koa Health: Is Koa Health still operating?

Yes. PsychPlus acquired it in June 2026 and the brand and platform continue. It is not a shutdown, but the ownership and clinical direction have changed.

Paige: What exactly is FDA authorised?

Paige Prostate Detect, as an adjunct for identifying areas of interest on digitised prostate core needle biopsy slides, viewed through the Paige FullFocus viewer on a compatible scanner. Nothing else in the portfolio holds that authorisation in the United States.

Koa Health: Who buys Koa Health?

Employers, health plans and health systems. It is not sold direct to individuals.

Paige: Is the European position broader?

Yes. The Paige Prostate suite including grading and quantification received IVDR certification in 2025, which covers more than the United States authorisation.

Koa Health: How is it priced?

Per employee or per member per month, quoted rather than published, with the rate depending on which steps of the care ladder are in scope.

Paige: What did the pivotal study measure?

Pathologist cancer detection on individual slide images improved, with reported reductions in false negative and false positive readings. It measured pathologist performance with the tool, not standalone algorithm accuracy.

Koa Health: Does it provide access to psychiatrists?

Clinical access is included in the higher tiers, and the PsychPlus acquisition adds psychiatry provider capacity in the United States. Confirm what your specific contract covers.

Paige: Who owns Paige now?

Tempus AI acquired Paige in 2025. Products remain branded Paige.

Share

Related pages

More on Koa Health

More on Paige

Keep looking

Other head to heads